par Peeters, Marc;Price, Tim;Van Laethem, Jean-Luc
Référence The oncologist, 14, 1, page (29-39)
Publication Publié, 2009-01
Référence The oncologist, 14, 1, page (29-39)
Publication Publié, 2009-01
Article révisé par les pairs
Titre: |
|
Auteur: | Peeters, Marc; Price, Tim; Van Laethem, Jean-Luc |
Informations sur la publication: | The oncologist, 14, 1, page (29-39) |
Statut de publication: | Publié, 2009-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Cetuximab |
EGFR | |
MCRC | |
Monotherapy | |
Panitumumab | |
MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
Antineoplastic Agents -- therapeutic use | |
Clinical Trials, Phase II as Topic | |
Clinical Trials, Phase III as Topic | |
Colorectal Neoplasms -- drug therapy -- enzymology -- pathology | |
Female | |
Humans | |
Male | |
Neoplasm Metastasis | |
Randomized Controlled Trials as Topic | |
Receptor, Epidermal Growth Factor -- antagonists & inhibitors | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1083-7159 |
info:doi/10.1634/theoncologist.2008-0167 | |
info:pii/theoncologist.2008-0167 | |
info:scp/61449162243 | |
info:pmid/19144681 |